en Experimental Neurobiology

Cited by CrossRef (12)

  1. Donghyun Park, Darine Froy N. Mabunga, Keremkleroo Jym Adil, Onjeon Ryu, Schley Valencia, Ryeongeun Kim, Hee Jin Kim, Jae Hoon Cheong, Kyung Ja Kwon, Hahn Young Kim, Seol-Heui Han, Se Jin Jeon, Chan Young Shin. Synergistic efficacy and diminished adverse effect profile of composite treatment of several ADHD medications. Neuropharmacology 2021;187:108494
    https://doi.org/10.1016/j.neuropharm.2021.108494
  2. Anna Janus, Klaudia Lustyk, Karolina Pytka. MK-801 and cognitive functions: Investigating the behavioral effects of a non-competitive NMDA receptor antagonist. Psychopharmacology 2023;240:2435
    https://doi.org/10.1007/s00213-023-06454-z
  3. Holger Rosenbrock, Cornelia Dorner-Ciossek, Riccardo Giovannini, Bernhard Schmid, Niklas Schuelert. Effects of the Glycine Transporter-1 Inhibitor Iclepertin (BI 425809) on Sensory Processing, Neural Network Function, and Cognition in Animal Models Related to Schizophrenia. J Pharmacol Exp Ther 2022;382:223
    https://doi.org/10.1124/jpet.121.001071
  4. Keke Cui, Zhipeng Yu, Le Xu, Wangcong Jiang, Luwan Wang, Xiangqun Wang, Dandan Zou, Jiajie Gu, Feng Gao, Xiaoqing Zhang, Zhengchun Wang. Behavioral features and disorganization of oscillatory activity in C57BL/6J mice after acute low dose MK-801 administration. Front. Neurosci. 2022;16
    https://doi.org/10.3389/fnins.2022.1001869
  5. Won-Seok Lee, Bo-Eun Yoon. Necessity of an Integrative Animal Model for a Comprehensive Study of Attention-Deficit/Hyperactivity Disorder. Biomedicines 2023;11:1260
    https://doi.org/10.3390/biomedicines11051260
  6. Yu Ri Kwon, Ji-Hyun Kim, Sanghyun Lee, Hyun Young Kim, Eun Ju Cho. Protective effects of Populus tomentiglandulosa against cognitive impairment by regulating oxidative stress in an amyloid beta25–35-induced Alzheimer's disease mouse model. Nutr Res Pract 2022;16:173
    https://doi.org/10.4162/nrp.2022.16.2.173
  7. Bo Pan, Yuting Wang, Yiwen Shi, Qianzhan Yang, Bing Han, Xiaoli Zhu, Yanqing Liu. Altered expression levels of miR-144-3p and ATP1B2 are associated with schizophrenia. The World Journal of Biological Psychiatry 2022;23:666
    https://doi.org/10.1080/15622975.2021.2022757
  8. James J. Gattuso, Carey Wilson, Anthony J. Hannan, Thibault Renoir. Acute administration of the NMDA receptor antagonists ketamine and MK-801 reveals dysregulation of glutamatergic signalling and sensorimotor gating in the Sapap3 knockout mouse model of compulsive-like behaviour. Neuropharmacology 2023;239:109689
    https://doi.org/10.1016/j.neuropharm.2023.109689
  9. Charmaine J. M. Lim, Jack Bray, Sanna K. Janhunen, Bettina Platt, Gernot Riedel. Mouse Exploratory Behaviour in the Open Field with and without NAT-1 EEG Device: Effects of MK801 and Scopolamine. Biomolecules 2024;14:1008
    https://doi.org/10.3390/biom14081008
  10. Artem Sinegubov, Vyacheslav Dyachuk. Chronic exposure to MK-801 leads to olfactory deficits and reduced neurogenesis in the olfactory bulbs of adult male mice. Front. Behav. Neurosci. 2024;18
    https://doi.org/10.3389/fnbeh.2024.1441910
  11. Brandon Richardson, Courtney Clarke, Jacqueline Blundell, Francis R. Bambico. Therapeutic‐like activity of cannabidiolic acid methyl ester in the MK‐801 mouse model of schizophrenia: Role for cannabinoid CB1 and serotonin‐1A receptors. Eur J of Neuroscience 2024;59:2403
    https://doi.org/10.1111/ejn.16278
  12. Vasilina R. Gedzun, Iuliia A. Sukhanova, Gleb M. Aliper, Maria M. Kotova, Nikolai O. Melnik, Elizaveta B. Karimova, Anastasia S. Voronkova, Alina Coffman, Vsevolod V. Pavshintcev, Nikita A. Mitkin, Igor I. Doronin, Gennady A. Babkin, Anton V. Malyshev. From land to water: “Sunken” T-maze for associated learning in cichlid fish. Behavioural Brain Research 2024;471:115077
    https://doi.org/10.1016/j.bbr.2024.115077